CLBAX
Price
$40.32
Change
+$0.07 (+0.17%)
Updated
Jul 31 closing price
Net Assets
288.09B
MBACX
Price
$33.00
Change
+$0.05 (+0.15%)
Updated
Jul 31 closing price
Net Assets
448.9M
Interact to see
Advertisement

CLBAX vs MBACX

CLBAX vs MBACX Comparison Chart in %
View a ticker or compare two or three
VS
CLBAX vs. MBACX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLBAX is a Buy and MBACX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CLBAX has more cash in the bank: 288B vs. MBACX (449M). CLBAX pays higher dividends than MBACX: CLBAX (1.82) vs MBACX (0.90). CLBAX was incepted earlier than MBACX: CLBAX (24 years) vs MBACX (24 years). MBACX (2.18) is less costly to investors than CLBAX (0.58). MBACX is a more actively managed with annual turnover of: 201.00 vs. CLBAX (50.00). CLBAX has a lower initial minimum investment than MBACX: CLBAX (250) vs MBACX (1000). CLBAX annual gain was more profitable for investors over the last year : 11.32 vs. MBACX (8.32). CLBAX return over 5 years is better than : 34.10 vs. MBACX (-4.65).
CLBAXMBACXCLBAX / MBACX
Total Expense Ratio0.582.0828%
Annual Report Gross Expense Ratio0.582.1827%
Fund Existence24 years24 years-
Gain YTD8.4047.069119%
Front Load4%N/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets288B449M64,143%
Annual Yield % from dividends1.820.90201%
Returns for 1 year11.328.32136%
Returns for 3 years38.6217.94215%
Returns for 5 years34.10-4.65-733%
Returns for 10 years93.4511.45816%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CURX0.210.01
+7.32%
Curanex Pharmaceuticals Inc.
UFI6.400.26
+4.23%
UNIFI
MNTN9.22-0.01
-0.11%
MNTN Inc.
BRO70.40-0.47
-0.66%
Brown & Brown
TOWN37.91-0.30
-0.79%
TowneBank